Ajanta Pharma Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI LODR'.
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Income Tax Department conducted a search under the Income Tax Act, 1961 at some of Ajanta Pharma's offices and manufacturing units on 19th August 2025, and the search was ongoing as of the disclosure date (20th August 2025). The company stated it is fully cooperating with officials and providing all clarifications and details sought. Ajanta Pharma clarified that business operations continued as usual and were not impacted by the search. The company also denied social media rumors and attributed the recent significant share price movement across exchanges to market dynamics rather than any specific event.
Tax searches often create short-term uncertainty and volatility around the stock, and the company's attempt to link the recent price movement to market forces (rather than leaks) suggests it is trying to manage sentiment. Investors should watch for follow-up disclosures on the outcome of the search, as any tax demand or penalty could affect future earnings.